GlobeNewswire

EPAM Acquires Continuum, Expanding Global Innovation, Design and Physical Product Development Capabilities

Share

NEWTOWN, Pa., March  15, 2018  (GLOBE NEWSWIRE) -- EPAM Systems, Inc. (NYSE:EPAM), a leading global provider of digital platform engineering and software development services, today announced its acquisition of Continuum, an innovation design firm headquartered in Boston with studios in Milan, Seoul, and Shanghai. Continuum partners with Fortune 500 clients in the healthcare, financial services, travel and hospitality, and consumer products industries to deliver value through four practices: Strategy, Physical/Digital Design, Technology and Made Real Lab.

The acquisition strengthens EPAM's innovation consulting capabilities and enhances existing digital and service design practices by introducing a human-centered approach to physical design and product development. Continuum's studios and the Made Real Lab are unique spaces that enable teams to collaborate throughout the entire iterative product development process by combining advanced prototyping technologies including mechanical, electrical and robotics engineering, together with AR/VR experimentation tools.

"The addition of Continuum expands our global presence in strategic markets in North America, Europe and Asia and brings to EPAM a deeper and more transformational, human-centered design approach, which will help us to better connect our customers' physical and digital business," said Arkadiy Dobkin, CEO & President, EPAM. "By introducing Continuum's approach into our network of EPAM Garages, we further mature our own innovation service offerings, while continuing to inspire and develop our people."

"By combining our capabilities, we will significantly improve our ability to turn innovative ideas, paired with disruptive technologies, into practical and scalable business solutions for our clients," said Gianfranco Zaccai, Founder of Continuum. "Joining EPAM enables us to introduce world-class innovation design and product development at scale to a Global 2000 client base, while bringing a comprehensive end-to-end offering to our existing clients."

Based on the estimated contribution of this acquisition, EPAM now expects revenue growth for full year 2018 to be at least 26% reported, or at least 24% in constant currency, after factoring in a 2% estimated currency tailwind, and GAAP EPS for the full year to now be at least $3.36 and Non-GAAP diluted EPS to now be at least $4.07. The Company's adjustments to its 2018 outlook relate solely to the impact of the Continuum acquisition.

To learn more about EPAM's digital strategy and experience design practice, visit us at https://www.epam.com/what-we-do/design.

About EPAM Systems
Since 1993, EPAM Systems, Inc. (NYSE:EPAM) has leveraged its core engineering expertise to become a leading global product development and digital platform engineering services company. Through its 'Engineering DNA' and innovative strategy, consulting, and design capabilities, EPAM works in collaboration with its customers to deliver innovative solutions that turn complex business challenges into real business opportunities. EPAM's global teams serve customers in over 25 countries across North America, Europe, Asia, and Australia. EPAM is a recognized market leader among independent research agencies and was ranked #12 in FORBES 25 Fastest Growing Public Tech Companies, as a top information technology services company on FORTUNE'S 100 Fastest-Growing Companies, and as a top UK Digital Design & Build Agency. Learn more at http://www.epam.com/ and follow us on Twitter @EPAMSYSTEMS and LinkedIn.

About Continuum
Continuum is a global innovation design firm. We design products, services, and experiences that improve people's lives, in small and large ways, while taking our clients' businesses into the future. Our clients range from start-ups to Fortune 500 brands across the healthcare, financial services, mobility, and consumer products sectors. For over 35 years, Continuum has been recognized for outstanding innovation and design for projects spanning from medical device and consumer product development and design, to customer experience design and innovation capability. Learn more at http://www.continuumInnovation.com and follow us on Twitter @_Continuum and LinkedIn.

Non-GAAP Financial Measures
EPAM supplements results reported in accordance with United States generally accepted accounting principles, referred to as GAAP, with non-GAAP financial measures. Management believes these measures help illustrate underlying trends in EPAM's business and uses the measures to establish budgets and operational goals, communicate internally and externally, for managing EPAM's business and evaluating its performance. Management also believes these measures help investors compare EPAM's operating performance with its results in prior periods. EPAM anticipates that it will continue to report both GAAP and certain non-GAAP financial measures in its financial results, including non-GAAP results that exclude stock-based compensation expense, write-offs and recoveries, amortization of purchased intangible assets, goodwill impairment, legal settlements, foreign exchange gains and losses, acquisition-related costs, certain other one-time charges, the impact of U.S. tax reform, excess tax benefits related to stock compensation and the related effect on income taxes. Management also compares operating results on a basis of "constant currency," which is also a non-GAAP financial measure. This measure excludes the effect of foreign currency exchange rate fluctuations by translating the current period revenues and expenses into U.S. dollars at the weighted average exchange rates of the prior period of comparison. Because EPAM's reported non-GAAP financial measures are not calculated according to GAAP, these measures are not comparable to GAAP and may not be comparable to similarly described non-GAAP measures reported by other companies within EPAM's industry. Consequently, EPAM's non-GAAP financial measures should not be evaluated in isolation or supplant comparable GAAP measures, but, rather, should be considered together with the information in EPAM's consolidated financial statements, which are prepared in accordance with GAAP.

Forward-Looking Statements
This press release includes statements which may constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the accuracy of which are necessarily subject to risks, uncertainties, and assumptions as to future events that may not prove to be accurate. Factors that could cause actual results to differ materially from those expressed or implied include general economic conditions and the factors discussed in our most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. EPAM undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities law.

EPAM SYSTEMS, INC. AND SUBSIDIARIES
Reconciliations of Guidance Non-GAAP Measures to Comparable GAAP Measures
 (Unaudited)

The below guidance constitutes forward-looking statements within the meaning of the federal securities laws and is based on a number of assumptions that are subject to change and many of which are outside the control of the Company. Actual results may differ materially from the Company's expectations depending on factors discussed in the Company's filings with the Securities and Exchange Commission.

Reconciliation of revenue growth at constant currency to revenue growth as reported under GAAP is presented in the table below:

    Full Year 2018  
Revenue growth at constant currency (at least) (1)   24 %  
Foreign exchange rates impact   2 %  
Revenue growth (at least)   26 %  
  1. Constant currency revenue results are calculated by translating current period projected revenues in local currency into U.S. dollars at the weighted average exchange rates of the comparable prior period.

Reconciliation of GAAP to non-GAAP diluted earnings per share guidance is presented in the table below:

    Full Year 2018  
GAAP diluted earnings per share (at least) $ 3.36    
Stock-based compensation expenses   1.01    
Included in cost of revenues   0.46    
Included in selling, general and administrative expenses   0.55    
Amortization of purchased intangible assets   0.14    
Foreign exchange loss   0.12    
Provision for income taxes:      
Tax effect on non-GAAP adjustments   (0.28)    
Excess tax benefits related to stock-based compensation   (0.28)    
Non-GAAP diluted earnings per share (at least) $ 4.07    

For media, contact: Danielle Ruess-Saltz
267.978.7688, danielle_ruess-saltz@epam.com For investor relations, contact: David Straube
david_straube@epam.com 




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: EPAM Systems, Inc via Globenewswire

About GlobeNewswire

GlobeNewswire
GlobeNewswire



Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Elanders AB: Rapport från årsstämman 202419.4.2024 14:18:43 CEST | Pressmeddelande

Stämman, som leddes av styrelsens ordförande Dan Frohm, beslöt att: fastställa resultat- och balansräkningen samt koncernresultat- och koncernbalansräkningen,bevilja styrelsens ledamöter och verkställande direktören ansvarsfrihet för verksamhetsåret 2023,enligt styrelsens förslag i kallelsen fastställa att utdelning för 2023 lämnas med 4,15 kronor per aktie samt att avstämningsdagen för utdelning är den 23 april 2024, vilket innebär att utdelningen beräknas utsändas genom Euroclear Sweden AB den 26 april 2024,enligt förslaget i kallelsen för verksamhetsåret 2024 bevilja styrelsen arvode inklusive utskottsarbete om totalt 4 512 600 kronor att fördelas inom styrelsen såsom angivits i kallelsen,enligt förslaget i kallelsen till styrelseledamöter för tiden intill dess att årsstämman 2025 hållits utse: Carl Bennet (omval) Ulrika Dellby (omval) Eva Elmstedt (omval) Dan Frohm (omval) Erik Gabrielson (omval) Anna Hallberg (omval) Anne Lenerius (omval) Magnus Nilsson (omval) Johan Trouvé (omval

Elanders AB: Delårsrapport januari – mars 202419.4.2024 10:00:00 CEST | Pressmeddelande

Första kvartalet 2024 Omsättningen uppgick till 3 268 (3 589) Mkr. Det motsvarade en organisk omsättningsminskning om nio procent, om förvärv samt nedlagd verksamhet exkluderas och oförändrade valutakurser används. Denna minskning var främst ett resultat av en svagare marknad samt lägre fraktpriser och volymer inom förmedlingen av Air & Sea-transporter.Justerad EBITA uppgick till 180 (217) Mkr, vilket motsvarade en justerad EBITA-marginal om 5,5 (6,0) procent.Rörelseresultatet belastades med engångsposter om -26 (-67) Mkr som huvudsakligen avsåg förvärvskostnader.Justerat nettoresultat uppgick till 32 (77) Mkr, motsvarande 0,89 (2,16) kronor per aktie.Operativt kassaflöde justerat för köpeskillingar för förvärv ökade till 641 (512) Mkr. Operativt kassaflöde inklusive förvärv uppgick till 121 (512) Mkr.Cash conversion ökade till 137 (122) procent, om köpeskillingar för förvärv exkluderas.I februari 2024 förvärvade Elanders nästan 90 procent av aktierna i det engelska bolaget Bishopsgate

HMS Networks har genomfört en riktad nyemission av 3 500 000 aktier och tillförs 1 400 miljoner SEK17.4.2024 22:45:00 CEST | Pressmeddelande

INTE AVSETT FÖR, OCH FÅR INTE, OFFENTLIGGÖRAS, PUBLICERAS ELLER DISTRIBUERAS, HELT ELLER DELVIS, DIREKT ELLER INDIREKT, INOM ELLER TILL USA (INNEFATTANDE DESS TERRITORIER OCH BESITTNINGAR, VARJE STAT I USA SAMT DISTRICT OF COLUMBIA), AUSTRALIEN, KANADA, JAPAN, SYDAFRIKA ELLER NÅGON ANNAN JURISDIKTION DÄR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION VORE OLAGLIG ELLER KRÄVA REGISTRERING ELLER ANDRA ÅTGÄRDER. DETTA PRESSMEDDELANDE UTGÖR INTE NÅGOT PROSPEKT OCH UTGÖR INTE NÅGOT ERBJUDANDE ATT SÄLJA ELLER FÖRVÄRVA DE VÄRDEPAPPER SOM BESKRIVS HÄRI, OCH DET SKA INTE SKE NÅGON FÖRSÄLJNING AV DE VÄRDEPAPPER SOM BESKRIVS HÄRI TILL ELLER INOM NÅGON JURISDIKTION DÄR SÅDANT ERBJUDANDE ELLER FÖRSÄLJNING VORE OLAGLIG FÖRE REGISTRERING ELLER KVALIFICERING ENLIGT VÄRDEPAPPERSREGLERNA I SÅDAN JURISDIKTION. HMS Networks AB (publ) (“HMS” eller "Bolaget") har, med stöd av bemyndigandet från den extra bolagsstämman den 26 januari 2024, beslutat att genomföra en riktad nyemission av 3 500 000 aktier til

HMS Networks utreder förutsättningarna för att genomföra en riktad nyemission av aktier om cirka 1 400 miljoner SEK17.4.2024 17:31:00 CEST | Pressmeddelande

INTE AVSETT FÖR, OCH FÅR INTE, OFFENTLIGGÖRAS, PUBLICERAS ELLER DISTRIBUERAS, HELT ELLER DELVIS, DIREKT ELLER INDIREKT, INOM ELLER TILL USA (INNEFATTANDE DESS TERRITORIER OCH BESITTNINGAR, VARJE STAT I USA SAMT DISTRICT OF COLUMBIA), AUSTRALIEN, KANADA, JAPAN, SYDAFRIKA ELLER NÅGON ANNAN JURISDIKTION DÄR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION VORE OLAGLIG ELLER KRÄVA REGISTRERING ELLER ANDRA ÅTGÄRDER. DETTA PRESSMEDDELANDE UTGÖR INTE NÅGOT PROSPEKT OCH UTGÖR INTE NÅGOT ERBJUDANDE ATT SÄLJA ELLER FÖRVÄRVA DE VÄRDEPAPPER SOM BESKRIVS HÄRI, OCH DET SKA INTE SKE NÅGON FÖRSÄLJNING AV DE VÄRDEPAPPER SOM BESKRIVS HÄRI TILL ELLER INOM NÅGON JURISDIKTION DÄR SÅDANT ERBJUDANDE ELLER FÖRSÄLJNING VORE OLAGLIG FÖRE REGISTRERING ELLER KVALIFICERING ENLIGT VÄRDEPAPPERSREGLERNA I SÅDAN JURISDIKTION. I enlighet med vad HMS Networks AB (publ) (“HMS” eller “Bolaget”) tidigare har kommunicerat har Bolagets styrelse uppdragit åt Skandinaviska Enskilda Banken AB (”SEB”) att utreda förutsättningarn

KALLELSE TILL ÅRSSTÄMMA I CORLINE BIOMEDICAL AB (PUBL)16.4.2024 14:40:36 CEST | Pressmeddelande

Aktieägarna i Corline Biomedical AB (publ), org.nr 556417-0743 ("Bolaget"), kallas härmed till årsstämma onsdagen den 15 maj 2024 klockan 14.00 i Advokatfirman Lindahls lokaler på Vaksalagatan 10 i Uppsala. Anmälan m.m. Aktieägare som önskar delta i årsstämman måste: dels vara registrerad i eget namn (inte förvaltarregistrerad) i den av Euroclear Sweden AB förda aktieboken måndagen den 6 maj 2024,dels anmäla sitt deltagande så att anmälan är Bolaget till handa senast måndagen den 13 maj 2024 (den s.k. avstämningsdagen). Anmälan kan göras via e-post till olle.sward.brattstrom@lindahl.se eller per post till adressen Advokatfirman Lindahl KB, att. Olle Swärd Brattström, Box 1203, 751 42 Uppsala. Vid anmälan uppges aktieägarens namn, person- eller organisationsnummer (eller motsvarande) och gärna adress, telefonnummer, aktieinnehav, uppgift om eventuella biträden (högst två), samt i förekommande fall uppgift om ställföreträdare eller ombud. Förvaltarregistrerade aktier Aktieägare som låtit

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye